Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-30 Sale |
2025-05-01 7:07 pm |
Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
736,767 | $1.3816 | $1,017,919 | 3,104,139 (Indirect) |
View |
| 2025-04-25 Sale |
2025-04-29 7:26 pm |
Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,519,952 | $1.8059 | $2,744,946 | 3,840,906 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-21 Tax Withholding |
2025-05-23 4:58 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
19,904 | $1.15 | 2,521,797 (Direct) |
View |
| 2025-05-14 Tax Withholding |
2025-05-16 4:21 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer |
99 | $1.14 | 4,320 (Direct) |
View |
| 2025-05-14 Tax Withholding |
2025-05-16 4:20 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
184 | $1.14 | 36,323 (Direct) |
View |
| 2025-05-14 Tax Withholding |
2025-05-16 4:18 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
403 | $1.14 | 16,089 (Direct) |
View |
| 2025-05-14 Tax Withholding |
2025-05-16 4:17 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
613 | $1.14 | 66,534 (Direct) |
View |
| 2025-05-14 Tax Withholding |
2025-05-16 4:16 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
60,257 | $1.14 | 2,541,701 (Direct) |
View |
| 2025-04-17 Tax Withholding |
2025-04-18 3:51 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
558 | $1.81 | 36,507 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:32 pm |
N/A 2035-03-31 |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
15,616 | $0 | 15,616 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 4:30 pm |
N/A 2035-03-31 |
Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer |
35,209 | $0 | 35,209 (Direct) |
View |
Ownership |
2025-04-03 4:28 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer |
0 | $0 | 169,340 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 5:36 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer |
31,900 | $0 | 31,900 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 5:31 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
93,693 | $0 | 93,693 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 5:28 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
109,309 | $0 | 109,309 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 5:24 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
78,078 | $0 | 78,078 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 5:21 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
140,540 | $0 | 140,540 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 5:13 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Cuillerot Jean-Marie Chief Medical Officer |
78,078 | $0 | 78,078 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 5:11 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
530,930 | $0 | 530,930 (Direct) |
View |
| 2025-02-21 Tax Withholding |
2025-02-25 4:09 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
19,904 | $5.54 | 2,601,958 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 5:00 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer |
116 | $5.42 | 4,419 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:59 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
217 | $5.42 | 37,065 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:55 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
434 | $5.42 | 26,088 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:54 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
469 | $5.42 | 16,492 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:53 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
724 | $5.42 | 67,147 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:52 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
37,731 | $5.42 | 2,621,862 (Direct) |
View |
| 2025-01-17 Tax Withholding |
2025-01-22 4:15 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
659 | $5.78 | 37,282 (Direct) |
View |
| 2024-03-01 Option Award |
2024-11-27 6:11 pm |
N/A 2034-02-28 |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
67,567 | $0 | 67,567 (Direct) |
View |
| 2024-03-01 Option Award |
2024-11-27 6:10 pm |
N/A 2034-02-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
90,090 | $0 | 90,090 (Direct) |
View |
| 2024-03-01 Option Award |
2024-11-27 6:08 pm |
N/A 2034-02-28 |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
45,045 | $0 | 45,045 (Direct) |
View |
| 2024-03-01 Option Award |
2024-11-27 6:06 pm |
N/A 2034-02-28 |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
90,090 | $0 | 90,090 (Direct) |
View |
| 2024-03-01 Option Award |
2024-11-27 6:04 pm |
N/A 2034-02-28 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
315,316 | $0 | 315,316 (Direct) |
View |
| 2024-11-21 Tax Withholding |
2024-11-25 4:29 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
19,910 | $6.44 | 2,659,593 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:32 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer |
99 | $7.92 | 4,535 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:31 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
184 | $7.92 | 37,941 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
368 | $7.92 | 26,522 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:29 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
402 | $7.92 | 16,961 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:28 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
613 | $7.92 | 67,871 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:26 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
60,256 | $7.92 | 2,679,503 (Direct) |
View |